| Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management E Sechi, L Cacciaguerra, JJ Chen, S Mariotto, G Fadda, A Dinoto, ... Frontiers in neurology 13, 885218, 2022 | 170 | 2022 |
| Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients S Karteri, J Bruna, AA Argyriou, S Mariotto, R Velasco, M Alemany, ... Journal of the Peripheral Nervous System 27 (2), 166-174, 2022 | 33 | 2022 |
| Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD A Dinoto, E Sechi, S Ferrari, A Gajofatto, R Orlandi, P Solla, A Maccabeo, ... Multiple Sclerosis and Related Disorders 58, 103424, 2022 | 27 | 2022 |
| Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection? S Mariotto, S Carta, A Dinoto, G Lippi, GL Salvagno, L Masin, D Alberti, ... European Journal of Neurology 29 (6), 1855-1858, 2022 | 24 | 2022 |
| Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review A Dinoto, M Cheli, A Bratina, A Sartori, P Manganotti Journal of neuroimmunology 356, 577586, 2021 | 24 | 2021 |
| Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease A Dinoto, E Sechi, EP Flanagan, S Ferrari, P Solla, S Mariotto, JJ Chen Frontiers in Neurology 13, 866824, 2022 | 22 | 2022 |
| SARS-CoV-2 pandemic and epilepsy: the impact on emergency department attendances for seizures M Cheli, A Dinoto, S Olivo, M Tomaselli, D Stokelj, F Cominotto, F Brigo, ... Seizure 82, 23-26, 2020 | 19 | 2020 |
| Treatment options in refractory autoimmune encephalitis A Dinoto, S Ferrari, S Mariotto CNS drugs 36 (9), 919-931, 2022 | 17 | 2022 |
| More efficient complement activation by anti–aquaporin-4 compared with anti–myelin oligodendrocyte glycoprotein antibodies M Lerch, K Schanda, E Lafon, R Würzner, S Mariotto, A Dinoto, ... Neurology: Neuroimmunology & Neuroinflammation 10 (1), e200059, 2022 | 14 | 2022 |
| Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder A Bauer, D Rudzki, K Berek, A Dinoto, C Lechner, EM Wendel, H Hegen, ... Frontiers in immunology 13, 1037812, 2022 | 14 | 2022 |
| Effects of a cooling vest with sham condition on walking capacity in heat-sensitive people with multiple sclerosis A Buoite Stella, F Pasquin, SA Morrison, ME Morelli, A Dinoto, A Bratina, ... European Journal of Applied Physiology 120, 2467-2476, 2020 | 14 | 2020 |
| ASL MRI and 18F-FDG-PET in autoimmune limbic encephalitis: clues from two paradigmatic cases A Dinoto, M Cheli, M Ajčević, F Dore, C Crisafulli, M Ukmar, A Sartori, ... Neurological Sciences 42, 3423-3425, 2021 | 13 | 2021 |
| Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review A Dinoto, E Mantovani, S Ferrari, S Mariotto, S Tamburin European Journal of Neurology 30 (3), 774-781, 2023 | 11 | 2023 |
| Telemedicine during the SARS-Cov-2 pandemic lockdown: Monitoring stress and quality of sleep in patients with epilepsy S Olivo, M Cheli, A Dinoto, D Stokelj, M Tomaselli, P Manganotti Epilepsy & Behavior 118, 107864, 2021 | 10 | 2021 |
| Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis ME Morelli, S Baldini, A Sartori, L D’Acunto, A Dinoto, A Bosco, A Bratina, ... Neurological Sciences 41, 2893-2904, 2020 | 10 | 2020 |
| Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses M Spatola, N Nziza, W Jung, Y Deng, D Yuan, A Dinoto, S Bozzetti, ... Brain 146 (10), 4292-4305, 2023 | 9 | 2023 |
| Autoimmune encephalitis misdiagnosis and mimics A Dinoto, P Zara, S Mariotto, S Ferrari, EP Flanagan, A Budhram, ... Journal of neuroimmunology 378, 578071, 2023 | 9 | 2023 |
| Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders A Dinoto, M Gastaldi, R Iorio, S Marini, V Damato, A Farina, M Zoccarato, ... Multiple Sclerosis and Related Disorders 63, 103827, 2022 | 9 | 2022 |
| Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach A Dinoto, GU Borin, G Campana, S Carta, S Ferrari, S Mariotto European Journal of Neurology 29 (11), 3466-3472, 2022 | 8 | 2022 |
| Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma A Dinoto, A McKeon, G Vattemi, S Carta, S Ferrari, S Mariotto Journal of neuroimmunology 368, 577882, 2022 | 8 | 2022 |
